These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7584926)
1. Endocrine and auto-paracrine factors in the pathogenesis of primary hypertension. Takeda R; Miyamori I Hypertens Res; 1995 Sep; 18(3):171-9. PubMed ID: 7584926 [TBL] [Abstract][Full Text] [Related]
2. Local hormonal factors (intracrine, autocrine, and paracrine) in hypertension. Carretero OA; Scicli AG Hypertension; 1991 Sep; 18(3 Suppl):I58-69. PubMed ID: 1889859 [TBL] [Abstract][Full Text] [Related]
3. Endothelin as a regulator of cardiovascular function in health and disease. Haynes WG; Webb DJ J Hypertens; 1998 Aug; 16(8):1081-98. PubMed ID: 9794709 [TBL] [Abstract][Full Text] [Related]
4. Role of renal and extrarenal renin-angiotensin system in the mechanism of arterial hypertension and its sequelae. Rosenthal J Steroids; 1993 Dec; 58(12):566-72. PubMed ID: 8116011 [TBL] [Abstract][Full Text] [Related]
5. Recent advances in endothelin research on cardiovascular and endocrine systems. Naruse M; Naruse K; Demura H Endocr J; 1994 Oct; 41(5):491-507. PubMed ID: 7889108 [TBL] [Abstract][Full Text] [Related]
6. Contribution of the endothelin and renin-angiotensin systems to the vascular changes in rats chronically treated with ouabain. Xavier FE; Yogi A; Callera GE; Tostes RC; Alvarez Y; Salaices M; Alonso MJ; Rossoni LV Br J Pharmacol; 2004 Nov; 143(6):794-802. PubMed ID: 15477225 [TBL] [Abstract][Full Text] [Related]
7. The role of endothelin in hypertension. Rothermund L; Paul M Curr Opin Nephrol Hypertens; 1998 Jul; 7(4):451-6. PubMed ID: 9690046 [TBL] [Abstract][Full Text] [Related]
8. Peptides as targets for antihypertensive drug development. Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647 [TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinase activity regulation role of angiotensin and endothelin systems in vascular smooth muscle cells. Kubo T; Ibusuki T; Chiba S; Kambe T; Fukumori R Eur J Pharmacol; 2001 Jan; 411(1-2):27-34. PubMed ID: 11137855 [TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and clinical physiology of hypertension. Singh M; Mensah GA; Bakris G Cardiol Clin; 2010 Nov; 28(4):545-59. PubMed ID: 20937440 [TBL] [Abstract][Full Text] [Related]
12. Endothelin in hypertension. Schiffrin EL Curr Opin Cardiol; 1995 Sep; 10(5):485-94. PubMed ID: 7496057 [TBL] [Abstract][Full Text] [Related]
13. [Hormonal regulation in cardiac function--endocrine, paracrine, autocrine]. Yamasawa M; Shimada K Nihon Rinsho; 1993 May; 51(5):1171-6. PubMed ID: 8331783 [TBL] [Abstract][Full Text] [Related]
14. The endothelin system and its antagonism in chronic kidney disease. Dhaun N; Goddard J; Webb DJ J Am Soc Nephrol; 2006 Apr; 17(4):943-55. PubMed ID: 16540557 [TBL] [Abstract][Full Text] [Related]
15. Endothelin in vascular and endocrine systems: biological activities and its mechanisms of action. Takuwa Y Endocr J; 1993 Oct; 40(5):489-506. PubMed ID: 7951515 [TBL] [Abstract][Full Text] [Related]
16. Endothelin as a clinical target in the treatment of systemic hypertension. Prasad VS; Palaniswamy C; Frishman WH Cardiol Rev; 2009; 17(4):181-91. PubMed ID: 19525680 [TBL] [Abstract][Full Text] [Related]
17. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Weir MR; Dzau VJ Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573 [TBL] [Abstract][Full Text] [Related]
18. Hormonal and local factors in hypertension. Kaplan NM Am J Med Sci; 1991 Jun; 301(6):412-20. PubMed ID: 1828131 [TBL] [Abstract][Full Text] [Related]